National Health Investors (NHI) EPS (Weighted Average and Diluted) (2016 - 2025)
National Health Investors (NHI) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $0.8 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 16.67% year-over-year to $0.8, compared with a TTM value of $3.02 through Dec 2025, down 3.51%, and an annual FY2025 reading of $3.02, down 3.51% over the prior year.
- EPS (Weighted Average and Diluted) was $0.8 for Q4 2025 at National Health Investors, up from $0.69 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.96 in Q4 2024 and bottomed at $0.05 in Q4 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.66, with a median of $0.74 recorded in 2025.
- The sharpest move saw EPS (Weighted Average and Diluted) crashed 84.34% in 2021, then soared 1380.0% in 2023.
- Year by year, EPS (Weighted Average and Diluted) stood at $0.13 in 2021, then tumbled by 61.54% to $0.05 in 2022, then skyrocketed by 1380.0% to $0.74 in 2023, then rose by 29.73% to $0.96 in 2024, then decreased by 16.67% to $0.8 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for NHI at $0.8 in Q4 2025, $0.69 in Q3 2025, and $0.79 in Q2 2025.